GENEVA, April 27 -- NANJING QINLING PHARMACEUTICAL TECHNOLOGY COMPANY LIMITED (Building B, Phase I, Zhongdan Ecological Life Science Industrial Park, No. 3-1 Xinjinhu Road, Jiangbei New AreaNanjing, Jiangsu 210000), 南京芩领医药科技有限公司 (中国江苏省南京市江北新区新锦湖路3-1号中丹生态生命科学产业园一期B栋) filed a patent application (PCT/CN2023/128975) for "BAICALEIN TOPICAL FORMULATION AND USE THEREOF IN TREATMENT OF ATOPIC DERMATITIS" on Nov 01, 2023. With publication no. WO/2025/081...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.